Cargando…

Nuclear HKII-P-p53 (Ser15) Interaction is a Prognostic Biomarker for Chemoresponsiveness and Glycolytic Regulation in Epithelial Ovarian Cancer

SIMPLE SUMMARY: Hexokinase II (HKII) is a key glycolysis enzyme associated with tumorigenesis, but its molecular mechanism and pathophysiological role in chemoresistant ovarian cancer remain elusive. In this study, we delineate the novel mechanism showing that activated phosphorylated-p53 (P-p53 Ser...

Descripción completa

Detalles Bibliográficos
Autores principales:	Han, Chae Young, Patten, David A., Kim, Se Ik, Lim, Jung Jin, Chan, David W., Siu, Michelle K. Y., Han, Youngjin, Carmona, Euridice, Parks, Robin J., Lee, Cheol, Di, Li-Jun, Lu, Zhen, Chan, Karen K. L., Ku, Ja-Lok, Macdonald, Elizabeth A., Vanderhyden, Barbara C., Mes-Masson, Anne-Marie, Ngan, Hextan Y. S., Cheung, Annie N. Y., Song, Yong Sang, Bast, Robert C., Harper, Mary-Ellen, Tsang, Benjamin K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8306240/ https://www.ncbi.nlm.nih.gov/pubmed/34298618 http://dx.doi.org/10.3390/cancers13143399

Ejemplares similares

Predicting chemoresponsiveness in epithelial ovarian cancer patients using circulating small extracellular vesicle-derived plasma gelsolin
por: Gerber, Emma, et al.
Publicado: (2023)

Overview of a chemoresponse assay in ovarian cancer
por: Grendys, E. C., et al.
Publicado: (2014)

Prohibitin 1 interacts with p53 in the regulation of mitochondrial dynamics and chemoresistance in gynecologic cancers
por: Kong, Bao, et al.
Publicado: (2022)

Dissociation of HKII in retinal epithelial cells induces oxidative stress injury in the retina
por: Chu, Liqun, et al.
Publicado: (2019)

In vitro chemoresponse in metachronous pairs of gyneclologic cancers
por: Dalton, Heather J, et al.
Publicado: (2014)

Expression and Clinical Significance of HKII and HIF-1α in Grade Groups of Prostate Cancer
por: Sun, Xueqi, et al.
Publicado: (2021)

p21-Activated Kinases 1, 2 and 4 in Endometrial Cancers: Effects on Clinical Outcomes and Cell Proliferation
por: Siu, Michelle K. Y., et al.
Publicado: (2015)

Evaluation of chemoresponse assays as predictive markers
por: Korn, E L, et al.
Publicado: (2015)

Aberrant Cholesterol Metabolism in Ovarian Cancer: Identification of Novel Therapeutic Targets
por: He, Jiangnan, et al.
Publicado: (2021)

Molecular Biomarkers for the Early Detection of Ovarian Cancer
por: Zhang, Ruiqian, et al.
Publicado: (2022)

A patient with relapsed high-grade serous ovarian carcinoma with somatic RAD51C mutations treated with PARPi monotherapy: a case report
por: Ngu, Siew-Fei, et al.
Publicado: (2022)

Tumour Suppressive Function and Modulation of Programmed Cell Death 4 (PDCD4) in Ovarian Cancer
por: Wei, Na, et al.
Publicado: (2012)

Comment on: ‘Evaluation of chemoresponse assays as predictive markers'
por: Tian, C, et al.
Publicado: (2015)

Aberrant Activation of ERK/FOXM1 Signaling Cascade Triggers the Cell Migration/Invasion in Ovarian Cancer Cells
por: Lok, Gabriel T. M., et al.
Publicado: (2011)

Orchestrated Action of AMPK Activation and Combined VEGF/PD-1 Blockade with Lipid Metabolic Tunning as Multi-Target Therapeutics against Ovarian Cancers
por: Yung, Mingo M. H., et al.
Publicado: (2022)

Response to Comment on: ‘Evaluation of chemoresponse assays as predictive biomarkers'
por: Korn, E L, et al.
Publicado: (2015)

The Prognostic 97 Chemoresponse Gene Signature in Ovarian Cancer
por: Matondo, Abel, et al.
Publicado: (2017)

Dhcr24 activates the PI3K/Akt/HKII pathway and protects against dilated cardiomyopathy in mice
por: Dong, Wei, et al.
Publicado: (2018)

The Impact of the Tumor Microenvironment on Macrophage Polarization in Cancer Metastatic Progression
por: Wang, Huogang, et al.
Publicado: (2021)

Loss of Atoh1 from neurons regulating hypoxic and hypercapnic chemoresponses causes neonatal respiratory failure in mice
por: van der Heijden, Meike E, et al.
Publicado: (2018)

Chemical Sensing and Chemoresponsive Pumping with Conical-Pore Polymeric Membranes
por: Bush, Stevie N., et al.
Publicado: (2020)

Evaluation of an Isothermal Amplification HPV Assay on Self-Collected Vaginal Samples as Compared to Clinician-Collected Cervical Samples
por: Chan, Aaron H. Y., et al.
Publicado: (2023)

New Insights into Ferroptosis Initiating Therapies (FIT) by Targeting the Rewired Lipid Metabolism in Ovarian Cancer Peritoneal Metastases
por: Zhan, Shijie, et al.
Publicado: (2022)

Estrogen receptor modulators genistein, daidzein and ERB-041 inhibit cell migration, invasion, proliferation and sphere formation via modulation of FAK and PI3K/AKT signaling in ovarian cancer
por: Chan, Karen K. L., et al.
Publicado: (2018)

ROCK2 Promotes Osteosarcoma Growth and Glycolysis by Up-Regulating HKII via Phospho-PI3K/AKT Signalling
por: Deng, Binbin, et al.
Publicado: (2021)

The PI3K-Akt-mTOR pathway mediates renal pericyte-myofibroblast transition by enhancing glycolysis through HKII
por: Chen, Liangmei, et al.
Publicado: (2023)

Expression of Heat Shock Protein 70 Modulates the Chemoresponsiveness of Pancreatic Cancer
por: Hyun, Jong Jin, et al.
Publicado: (2013)

miRNA Profiles as a Predictor of Chemoresponsiveness in Wilms’ Tumor Blastema
por: Watson, Jenny A., et al.
Publicado: (2013)

Chemoresponse after non-curative gastrectomy for M1 gastric cancer
por: Shin, Hyun Beak, et al.
Publicado: (2015)

Design of Chemoresponsive Soft Matter Using Hydrogen-Bonded Liquid Crystals
por: Yu, Huaizhe, et al.
Publicado: (2021)

Electrochemical Fine-Tuning of the Chemoresponsiveness of Langmuir–Blodgett Graphene Oxide Films
por: Devida, Juan M., et al.
Publicado: (2023)

The Application of an Extracellular Vesicle-Based Biosensor in Early Diagnosis and Prediction of Chemoresponsiveness in Ovarian Cancer
por: Asare-Werehene, Meshach, et al.
Publicado: (2023)

Germline PALB2 Mutation in High-Risk Chinese Breast and/or Ovarian Cancer Patients
por: Kwong, Ava, et al.
Publicado: (2021)

Increased Expression of PITX2 Transcription Factor Contributes to Ovarian Cancer Progression
por: Fung, Frederic K. C., et al.
Publicado: (2012)

PFKFB3 Regulates Chemoresistance, Metastasis and Stemness via IAP Proteins and the NF-κB Signaling Pathway in Ovarian Cancer
por: Jiang, Yu-xin, et al.
Publicado: (2022)

Hexokinase 2 Regulates Ovarian Cancer Cell Migration, Invasion and Stemness via FAK/ERK1/2/MMP9/NANOG/SOX9 Signaling Cascades
por: Siu, Michelle K. Y., et al.
Publicado: (2019)

Human Papillomavirus Self-Sampling for Primary Cervical Cancer Screening in Under-Screened Women in Hong Kong during the COVID-19 Pandemic
por: Ngu, Siew-Fei, et al.
Publicado: (2022)

Surgery including fertility-sparing treatment of GTD
por: Ngu, Siew-Fei, et al.
Publicado: (2021)

The Stress-Inducible BCL2A1 Is Required for Ovarian Cancer Metastatic Progression in the Peritoneal Microenvironment
por: Liang, Rui, et al.
Publicado: (2021)

Towards first-principles molecular design of liquid crystal-based chemoresponsive systems
por: Roling, Luke T., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_eat9mfk5c827d2s8rlma6gl3bv